As the CEO of Seven Point One, Evan Lee spearheaded the development of AlzWIN, an FDA-registered, AI-powered cognitive screening solution that utilizes a simple one-minute voice test to identify early signs of impairment.

Under Evan's leadership, the company has secured 14 patents and established high-impact partnerships with global pharmaceutical leaders, major insurers, and clinics to streamline the dementia care continuum. Evan's mission is to empower primary-care providers with scalable tools that improve both clinic profitability and patient dignity, ensuring that proactive cognitive care becomes a universal standard in our aging society.